Voyager Therapeutics Inc (VYGR) — Cash Flow Quality Index
Voyager Therapeutics Inc (VYGR) has a Cash Flow Quality Index of -0.42x as of December 2023. Operating cash flow of $-23.76 Million is below net income of $56.40 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore VYGR cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Voyager Therapeutics Inc Cash Flow Quality Index (2020–2023)
Historical Cash Flow Quality Index for Voyager Therapeutics Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check VYGR cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Voyager Therapeutics Inc (2020–2023)
Year-by-year earnings quality comparison for Voyager Therapeutics Inc. For live market cap and the full company financial profile, see Voyager Therapeutics Inc market cap and net worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 0.59x | $77.92 Million | $132.33 Million | ▲ +122.4% |
| 2020 | -2.63x | $-96.72 Million | $36.74 Million | — |